Works matching DE "EMICIZUMAB"

Results: 176

A Unique Comparison of Tooth Extraction Before and After Emicizumab Prophylaxis in a Patient With Haemophilia A and Inhibitors.

Published in:

2025

By:

Zaizen, Miki;
Yagyuu, Takahiro;
Yata, Sachiko;
Nakamura, Hiroshi;
Imada, Mitsuhiko;
Yamakawa, Nobuhiro;
Nammour, Samir

Publication type:

Case Study

Concizumab, a Non-Replacement Therapy for Persons with Hemophilia with Inhibitors.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 9, p. 2961, doi. 10.3390/jcm14092961

By:

Castaman, Giancarlo;
Jimenez-Yuste, Victor;
Mahlangu, Johnny

Publication type:

Article

Emicizumab in severe hemophilia A.

Published in:

Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 422, doi. 10.5603/AHP.2021.0079

By:

Windyga, Jerzy

Publication type:

Article

Emicizumab in severe hemophilia A.

Published in:

Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 422, doi. 10.5603/AHP.2021.0079

By:

Windyga, Jerzy

Publication type:

Article

Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36891-x

By:

Valls, Raquel;
Wagg, Jonathan;
Paz-Priel, Ido;
Man, Gabriel;
Artigas, Laura;
Jaccard, Georges;
Coma, Mireia;
Schmitt, Christophe

Publication type:

Article

EMICIZUMAB THERAPY IN A HAEMOPHILIA PATIENT WITH PREVIOUS PULMONARY EMBOLISM.

Published in:

2020

By:

Holzmann, Jonathan;
Coulsen, Hayley;
Poulsen, Wendy;
McCosker, Joanna;
Harlen, Moana;
Brown, Simon

Publication type:

Letter

Prophylaxie de l'hémophilie en pédiatrie.

Published in:

Hematologie, 2024, v. 30, n. 6, p. 351, doi. 10.1684/hma.2024.1871

By:

Harroche, Annie;
Meunier, Sandrine

Publication type:

Article

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.

Published in:

JMIR Research Protocols, 2023, v. 12, n. 1, p. 950, doi. 10.2196/43091

By:

Fraticelli, Laurie;
Freyssenge, Julie;
Promé-Combel, Emilie;
Agnellet, Eléonore;
Dargaud, Yesim;
Chamouard, Valérie

Publication type:

Article

Emicizumab: A Review in Haemophilia A.

Published in:

Drugs, 2019, v. 79, n. 15, p. 1697, doi. 10.1007/s40265-019-01200-2

By:

Blair, Hannah A.

Publication type:

Article

Clinical pharmacology of emicizumab for the treatment of hemophilia A.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 9, p. 775, doi. 10.1080/17512433.2023.2243213

By:

Yoneyama, Koichiro;
Schmitt, Christophe;
Portron, Agnès;
Kiialainen, Anna;
Kotani, Naoki;
Jaminion, Felix;
Retout, Sylvie;
Adamkewicz, Joanne I

Publication type:

Article

Dental extractions on a patient with severe haemophilia A and inhibitors taking emicizumab prophylaxis. A case report and review.

Published in:

Oral Surgery (1752-2471), 2022, v. 15, n. 4, p. 592, doi. 10.1111/ors.12689

By:

Hamid, Aruche‐A‐Noor;
Smithson, Nigel

Publication type:

Article

Emicizumab prophylaxis in infants: Single‐centre experience.

Published in:

British Journal of Haematology, 2024, v. 204, n. 4, p. 1375, doi. 10.1111/bjh.19312

By:

Levy‐Mendelovich, Sarina;
Greenberg‐kushnir, Noa;
Budnik, Ivan;
Barg, Assaf Arie;
Cohen, Omri;
Avishai, Einat;
Barazani‐Brutman, Tami;
Livnat, Tami;
Kenet, Gili

Publication type:

Article

Current and future therapies for haemophilia—Beyond factor replacement therapies.

Published in:

British Journal of Haematology, 2023, v. 200, n. 1, p. 23, doi. 10.1111/bjh.18379

By:

Nogami, Keiji;
Shima, Midori

Publication type:

Article

Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis.

Published in:

Clinical & Experimental Medicine, 2024, v. 25, n. 1, p. 1, doi. 10.1007/s10238-024-01528-4

By:

Raventós, Aida;
Arias-Salgado, Elena G.;
Pérez, Alba;
Alvarez-Román, María Teresa;
Butta, Nora V.;
Monzon Manzano, Elena;
Acuña, Paula;
Jiménez-Yuste, Víctor;
Costa, Montserrat;
Bravo, María Isabel

Publication type:

Article

Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options.

Published in:

Pediatric Health, Medicine & Therapeutics, 2022, v. 13, p. 27, doi. 10.2147/PHMT.S293246

By:

Regling, Katherine;
Callaghan, Michael U;
Jr, Robert Sidonio

Publication type:

Article

Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database.

Published in:

International Journal of Clinical Pharmacy, 2023, v. 45, n. 3, p. 622, doi. 10.1007/s11096-022-01514-4

By:

Wei, Lianhui;
Tian, Ye;
Chen, Xiao;
Guo, Xiaojing;
Chen, Chenxin;
Zheng, Yi;
Xu, Jinfang;
Ye, Xiaofei

Publication type:

Article

Utilization of Emicizumab in Acquired Factor VIII Deficiency.

Published in:

American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.922326

By:

Hess, Kevin J.;
Patel, Preysi;
Joshi, Amogh M.;
Kotkiewicz, Adam

Publication type:

Article

Outcomes of Emicizumab in Acquired Hemophilia Patients: A Systematic Review.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241298661

By:

Ikbel, Ghachem;
Hela, Baccouche;
Yassine, Kaabar Mohamed;
Hamida, Khemiri;
Kamel, Ben Salem

Publication type:

Article

Absence of Effect of Emicizumab on D-Dimer Concentrations in Adult Patients with Severe Hemophilia A.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221143382

By:

Iarossi, Michael;
Lambert, Catherine;
Hermans, Cedric

Publication type:

Article

Regression Analysis to Estimate the Factor VIII Activity of Patients with Hemophilia A Without Inhibitor who Received Emicizumab Therapy.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221082992

By:

Hatayama, Yuki;
Motokura, Toru;
Hosoda, Yuzuru;
Suzuki, Sayaka;
Namba, Hiroya;
Kato, Konami;
Kojima, Nao;
Horie, Takuya;
Iwamoto, Takuya;
Yamashita, Noriko;
Ichikawa, Hitomi;
Fukuda, Tetsuya

Publication type:

Article

Statements about hemophilia A in Brazil: an expert Delphi panel.

Published in:

JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2022, v. 14, n. 1, p. 96, doi. 10.21115/JBES.v14.n1.p96-103

By:

da Silva Magliano, Carlos Alberto;
Padula Ribeiro Pereira, Ana Carolina;
Arinelli Fernandes, Roberta;
Sato-Kuwabara, Yukie;
Magalhães Loze, Priscilla;
da Silva Carlos, Nayara;
Elizabeth Mata, Verónica

Publication type:

Article

A real-world study comparing pre-post billed annualized bleed rates and total cost of care among non-inhibitor patients with hemophilia A switching from FVIII prophylaxis to emicizumab.

Published in:

Current Medical Research & Opinion, 2022, v. 38, n. 10, p. 1685, doi. 10.1080/03007995.2022.2105072

By:

Batt, Katharine;
Schultz, Bob G.;
Caicedo, Jorge;
Hollenbeak, Christopher S.;
Agrawal, Neha;
Chatterjee, Sagnik;
Bullano, Michael

Publication type:

Article

Breakthrough Bleeding Episodes at Minimum and Improvement in Quality of Life in a Child with Severe Hemophilia A with Inhibitors Treated with Emicizumab: A Case Report from Chile.

Published in:

American Journal of Case Reports, 2021, v. 22, p. 1, doi. 10.12659/AJCR.929598

By:

Abarca-Villaseca, Viviana;
Soto-Arellano, Verónica

Publication type:

Article

Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review.

Published in:

Pediatric Hematology & Oncology, 2022, v. 39, n. 5, p. 418, doi. 10.1080/08880018.2021.2004269

By:

Hassan, Eman;
Motwani, Jayashree

Publication type:

Article

Laboratory response to paradigm change in hemophilia treatment: How to monitor patients simultaneously treated with emicizumab and Factor VIII concentrate?

Published in:

Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 12, p. e248, doi. 10.1515/cclm-2023-0443

By:

Shafaati Lambert, Marjan;
Bruzelius, Maria;
Mahmoud Hourani Soutari, Nida;
Ranta, Susanna;
Antovic, Jovan P.

Publication type:

Article

Emicizumab, the factor VIII mimetic bi-specific monoclonal antibody and its measurement in plasma.

Published in:

Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 1, p. 365, doi. 10.1515/cclm-2020-0696

By:

Tripodi, Armando;
Chantarangkul, Veena;
Novembrino, Cristina;
Scalambrino, Erica;
Boscolo-Anzoletti, Massimo;
Clerici, Marigrazia;
Rossi, Federica;
Peyvandi, Flora

Publication type:

Article

Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study.

Published in:

European Journal of Haematology, 2024, v. 113, n. 5, p. 631, doi. 10.1111/ejh.14277

By:

Windyga, Jerzy;
Apte, Shashikant;
Frei‐Jones, Melissa;
Fujii, Teruhisa;
Lyu, Chuhl Joo;
Villarreal Martinez, Laura;
Sathar, Jameela;
Stasyshyn, Oleksandra;
Tran, Huyen;
Zozulya, Nadezhda;
Brown Frandsen, Renée;
Neergaard, Jesper Skov;
Thaung Zaw, Jay Jay;
Mahlangu, Johnny

Publication type:

Article

Cost‐effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.

Published in:

European Journal of Haematology, 2023, v. 110, n. 3, p. 262, doi. 10.1111/ejh.13901

By:

Kragh, Nana;
Tytula, Anna;
Pochopien, Michał;
Aballéa, Samuel;
Toumi, Mondher;
Hakimi, Zalmai;
Nazir, Jameel;
Bystrická, Linda;
Fatoye, Francis

Publication type:

Article

Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders.

Published in:

Annals of Hematology, 2024, v. 103, n. 8, p. 2647, doi. 10.1007/s00277-023-05287-2

By:

Shima, Midori

Publication type:

Article

A 9-year-old patient with severe haemophilia A complicated by factor VIII inhibitor treated with emicizumab -- case report and literature review.

Published in:

Journal of Pre-Clinical & Clinical Research, 2024, v. 18, n. 2, p. 128, doi. 10.26444/jpccr/187549

By:

Małgorzata Tomasik, Justyna;
Szuba, Joanna;
Chrostowski, Kacper;
Woźnica-Karczmarz, Irena

Publication type:

Article

Costs of the management of hemophilia A with inhibitors in Spain.

Published in:

Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 35, doi. 10.33393/grhta.2021.2234

By:

Bonanad, Santiago;
Álvarez, María Teresa;
Núñez, Ramiro;
Luis Poveda, José;
Gil, Beatriz;
Ruíz-Beato, Elena;
Durán, Ana;
Ivanova, Yoana;
Pérez-Román, Inés;
González-Domínguez, Almudena

Publication type:

Article

Health-related quality of life in children with severe hemophilia A on emicizumab prophylaxis.

Published in:

Egyptian Journal of Haematology, 2024, v. 49, n. 2, p. 192, doi. 10.4103/ejh.ejh_3_24

By:

Hassan, Ahmed S.;
Sherief, Laila M.;
Hamdy, Mona;
Abbas, Ahmed M.;
Elagamy, Osama

Publication type:

Article

Management of acquired haemophilia A in severe Covid‐19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 2, p. 908, doi. 10.1111/bcp.15598

By:

Gelbenegger, Georg;
Traby, Ludwig;
Rahimi, Nina;
Knöbl, Paul

Publication type:

Article

Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review.

Published in:

Clinical Pharmacokinetics, 2021, v. 60, n. 11, p. 1395, doi. 10.1007/s40262-021-01042-w

By:

Donners, Anouk A. M. T.;
Rademaker, Carin M. A.;
Bevers, Lisanne A. H.;
Huitema, Alwin D. R.;
Schutgens, Roger E. G.;
Egberts, Toine C. G.;
Fischer, Kathelijn

Publication type:

Article

Exposure–Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIII.

Published in:

Clinical Pharmacokinetics, 2021, v. 60, n. 7, p. 931, doi. 10.1007/s40262-021-01006-0

By:

Jonsson, Fredrik;
Schmitt, Christophe;
Petry, Claire;
Mercier, Francois;
Frey, Nicolas;
Retout, Sylvie

Publication type:

Article

Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A.

Published in:

Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1611, doi. 10.1007/s40262-020-00904-z

By:

Retout, Sylvie;
Schmitt, Christophe;
Petry, Claire;
Mercier, François;
Frey, Nicolas

Publication type:

Article

Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report.

Published in:

2023

By:

Albattat, Sami;
Alabdultaif, Abbas;
Albattat, Fatimah;
Albattat, Batla

Publication type:

Case Study

Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels.

Published in:

PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271330

By:

Hamedani, Nasim Shahidi;
Oldenburg, Johannes;
Pötzsch, Bernd;
Müller, Jens

Publication type:

Article

Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays.

Published in:

International Journal of Laboratory Hematology, 2020, v. 42, n. 2, p. e71, doi. 10.1111/ijlh.13114

By:

Adamkewicz, Joanne I.;
Kiialainen, Anna;
Paz‐Priel, Ido

Publication type:

Article

Emicizumab for infants and children with haemophilia A.

Published in:

British Journal of Haematology, 2020, v. 191, n. 2, p. 145, doi. 10.1111/bjh.16965

By:

Levy‐Mendelovich, Sarina

Publication type:

Article

Emicizumab treatment and monitoring in a paediatric cohort: real‐world data.

Published in:

British Journal of Haematology, 2020, v. 191, n. 2, p. 282, doi. 10.1111/bjh.16964

By:

Barg, Assaf A.;
Livnat, Tami;
Budnik, Ivan;
Avishai, Einat;
Brutman‐Barazani, Tami;
Tamarin, Ilia;
Bashari, Dalia;
Misgav, Mudi;
Kenet, Gili

Publication type:

Article

Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis‐treated haemophilia A patients with inhibitors.

Published in:

British Journal of Haematology, 2020, v. 190, n. 5, p. 727, doi. 10.1111/bjh.16574

By:

Furukawa, Shoko;
Nogami, Keiji;
Shimonishi, Naruto;
Nakajima, Yuto;
Matsumoto, Taisei;
Shima, Midori

Publication type:

Article

Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring.

Published in:

British Journal of Haematology, 2020, v. 189, n. 3, p. e100, doi. 10.1111/bjh.16512

By:

Biron‐Andreani, Christine;
Diaz‐Cau, Isabelle;
Ranc, Alexandre;
Navarro, Robert;
Leonardi, Christian;
Dischino, Marion;
Guy, Romuald;
Theron, Alexandre;
Garcia‐Gournay, Corinne;
Santagostino, Elena;
Schved, Jean‐François

Publication type:

Article

Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 257, doi. 10.1111/bjh.15525

By:

Yada, Koji;
Nogami, Keiji;
Shinozawa, Keiko;
Kitazawa, Takehisa;
Hattori, Kunihiro;
Amano, Kagehiro;
Fukutake, Katsuyuki;
Shima, Midori

Publication type:

Article

What proceduralists need to know about emicizumab for patients with hemophilia A.

Published in:

Baylor University Medical Center Proceedings, 2021, v. 34, n. 2, p. 334, doi. 10.1080/08998280.2020.1851628

By:

Pivalizza, Evan G.;
Escobar, Miguel

Publication type:

Article

Verification and Comparison of Chromogenic Factor VIII Activity Assays in Patients With Hemophilia Treated With and Without Emicizumab.

Published in:

Annals of Laboratory Medicine, 2023, v. 43, n. 1, p. 96, doi. 10.3343/alm.2023.43.1.96

By:

Min Young Lee;
Woo In Lee;
So Young Kang;
Myeong Hee Kim;
Young Shil Park

Publication type:

Article

Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 30, doi. 10.1002/cpdd.805

By:

Li, Haiyan;
Zhang, Weijiang;
Petry, Claire;
Li, Lindong;
Fernandez, Elena;
Kiialainen, Anna;
Feng, Sheng;
Hsu, Wanling;
Li, Li;
Wei, Yudong;
Schmitt, Christophe

Publication type:

Article

Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 702, doi. 10.1002/cpdd.617

By:

Kotani, Naoki;
Yoneyama, Koichiro;
Kawakami, Nobuhiko;
Shimuta, Tohru;
Fukase, Hiroyuki;
Kawanishi, Takehiko

Publication type:

Article

Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence.

Published in:

Journal of Blood Medicine, 2021, v. 12, p. 1031, doi. 10.2147/JBM.S260923

By:

Dargaud, Yesim;
Janbain, Maissa

Publication type:

Article

Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials.

Published in:

Journal of Blood Medicine, 2021, v. 12, p. 115, doi. 10.2147/JBM.S288283

By:

Klamroth, Robert;
Wojciechowski, Piotr;
Aballéa, Samuel;
Diamand, Françoise;
Hakimi, Zalmai;
Nazir, Jameel;
Abad-Franch, Lydia;
Lethagen, Stefan;
Santagostino, Elena;
Tarantino, Michael D

Publication type:

Article